MedPath

Supraglottic Jet Oxygenation and Ventilation for Gastrointestinal Endoscopy at High-altitude

Not Applicable
Conditions
High Altitude
Hypoxia
Interventions
Procedure: Nasal cannula oxygen supply
Procedure: Supraglottic jet oxygenation and ventilation
Registration Number
NCT05304923
Lead Sponsor
Peking University People's Hospital
Brief Summary

This study aims to determine whether the use of SOJV could reduce the rate of hypoxia during gastrointestinal endoscopic procedures in deeply sedated patients sedated at high altitude comparing to the supplemental oxygen administration via nasal cannula.

Detailed Description

The participants will be randomly allocated to either SJOV or nasal cannula oxygen supply in a 1:1 ratio using block randomization with variable block sizes of four or six randomized. In the nasal cannula oxygen supply group, oxygen supplementation at 2 liters min-1 is delivered via a nasal cannula. In the SJOV group, SJOV is conducted using a Wei nasal jet tube (WNJ, Well Lead Medical Co. Ltd, Guangzhou, China) which is connected to a manual jet ventilator (Well Lead Medical Co. Ltd, Guangzhou, China) via its jet port.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. 18 years or older;
  2. underwent routine gastrointestinal endoscopy under procedural sedation;
  3. consented to participate in this trial. -
Exclusion Criteria
  1. infection of the upper airway;
  2. anatomical abnormalities of the face, nose, and upper airway;
  3. coagulopathies;
  4. anticipated or known difficult airway;
  5. known allergy against propofol, soybeans, and egg;
  6. absence from the high-altitude environment during the past 3 months. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nasal cannula oxygen supplyNasal cannula oxygen supplyOxygen supplementation is delivered via a nasal cannula to the participants during sedation.
Supraglottic jet oxygenation and ventilationSupraglottic jet oxygenation and ventilationSupraglottic jet oxygenation and ventilation is conducted for the participants during sedation.
Primary Outcome Measures
NameTimeMethod
Hypoxia during sedationDuring sedation procedure

An SPO2 of 75 - 89% for \< 60 s

Secondary Outcome Measures
NameTimeMethod
respiratory-related complicationsDuring sedation procedure

pulmonary aspiration, respiratory depression (SPO2 = 90-95%) and severe hypoxia (SPO2 \< 75% or \< 90% for \> 60s)

cardiovascular-related complicationsDuring sedation procedure

hypotension (systolic blood pressure \< 90 mmHg), hypertension (systolic blood pressure \> 160 mmHg), bradycardia (heart rate \< 50 beats/min), tachycardia (heart rate \> 120 beats/min)

fatal complicationsfrom sedation initiation to 20 min after patients are awake

severe anaphylactic reactions, myocardial infarction, cardiac arrest and death

Trial Locations

Locations (1)

Tibet autonomous region people's hospital

🇨🇳

Lhasa, Tibet, China

© Copyright 2025. All Rights Reserved by MedPath